Our Spin-Offs

Digital Drugs

Flying Health is developing a new treatment class: Digital Drugs. A Digital Drug is a purely software-generated medical stimulus that triggers a direct physiological response. In short: your medicine is now on your mobile device, for you to stream your therapy. Digital Drugs address the causes of a disease rather than the symptoms, mostly through training, stimulating or modulating targeted parts of the nervous system.

Pipeline

Our products are researched and developed by scientists, with the highest ethical standards. We discover potential digital molecules in our science lab with our partners and turn them into Digital Drugs, a perfect balance of tech and science. Our Digital Drugs then undergo a clinical validation process and are brought to market. Finally, we help them scale in Germany and beyond.

Neuro / Mental Health

neuraltrain

Therapeutic area

Depression

Info

A Digital Drug that targets and modulates brain circuit mismatches typically seen in individuals with depression. This Digital Drug strengthens the ability to reproduce positive memories.

Product

OPTIMOOD

Pipeline

Discover

Develop

Pre-Clinical

Pilot

Pivotal

Certification

Launch

Ophthalmology

Dopavision

Therapeutic area

Myopia (Shortsightedness)

Info

A Digital Drug that treats myopia by targeting the neurotransmitter cascade that regulates the size of the eyeball.

Website

http://www.dopavision.com

Pipeline

Discover

Develop

Pre-Clinical

Pilot

Pivotal

Certification

Launch

Immunology

FHIMDX1

Pipeline

Discover

Develop

Pre-Clinical

Pilot

Pivotal

Certification

Launch

Get in touch

Lina Behrens

Director Digital Drugs

behrens@flyinghealth.com
+49 (0) 30 22 05 60 20

F.H. Incubator GmbH
Friedrichstr. 68
10117 Berlin